The stock price of Translational Development Acquisition Corp (NASDAQ: TDAC) has plunged by 0.00 when compared to previous closing price of 10.07, but the company has seen a 0.10% gain in its stock price over the last five trading sessions. globenewswire.com reported 2021-06-25 that NEW YORK, June 25, 2021 (GLOBE NEWSWIRE) — Trident Acquisitions Corp. (the “Company”) filed a Form 10-K/A for the period ended March 31, 2021 on June 25, 2021 after receiving a second notice from Nasdaq (the “Second Nasdaq Notice”) on June 21, 2021. The Second Nasdaq Notice stated that, since the Company had not yet filed its Form 10-Q for the period ended March 31, 2021 (the “Form 10-Q Deficiency”), such deficiency serves as an additional basis for delisting the Company’s securities. The Second Nasdaq Notice provided formal notification to the Company that the Panel will consider the Form 10-Q Deficiency at the hearing to be held in connection with the notice the Company received from Nasdaq on June 3, 2021, stating that the Company was not in compliance with Listing Rule IM-5101-2 (the “First Nasdaq Notice”). Today’s filing of the Form 10-K/A allows the Company to imminently file the Form 10-Q, seeking to clear the delinquency.
Is It Worth Investing in Translational Development Acquisition Corp (NASDAQ: TDAC) Right Now?
The public float for TDAC is 17.25M, and at present, short sellers hold a 0.01% of that float. The average trading volume of TDAC on March 27, 2025 was 188.46K shares.
TDAC’s Market Performance
The volatility ratio for the week is 0.38%, and the volatility levels for the past 30 days are at 0.34% for TDAC. The simple moving average for the past 20 days is 0.12% for TDAC’s stock, with a 0.27% simple moving average for the past 200 days.
TDAC Trading at 0.27% from the 50-Day Moving Average
After a stumble in the market that brought TDAC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -1.27% of loss for the given period.
Volatility was left at 0.34%, however, over the last 30 days, the volatility rate increased by 0.38%, as shares surge +0.50% for the moving average over the last 20 days.
During the last 5 trading sessions, TDAC rose by +0.10%, in comparison to the 20-day moving average, which settled at $10.06. In addition, Translational Development Acquisition Corp saw 0.60% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for TDAC
The total capital return value is set at 0.0.
Based on Translational Development Acquisition Corp (TDAC), the company’s capital structure generated 7.48 points at debt to capital in total, while cash flow to debt ratio is standing at -0.06.
Currently, EBITDA for the company is -0.49 million with net debt to EBITDA at -0.8. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.23.
Conclusion
In summary, Translational Development Acquisition Corp (TDAC) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
